MedPath
NMPA Approval

Ozagrel Sodium Injection

国药准字H20193226

May 21, 2024

Drug Information

奥扎格雷钠注射液

注射剂

2ml:40mg

化学药品

May 21, 2024

Company Information

Applicant Company

浙江省东阳市江北高科技工业园区

Manufacturing Company

浙江省东阳市江北高科技工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥扎格雷钠注射液 - NMPA 批准文号 | MedPath